Quart Barry D's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed Feb 4, 2026
- Accession no.
- 0001384243-26-000002
- Filed
- Feb 4, 2026
- Trade date
- Feb 2-4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $721.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Quart Barry DCIK 0001384243 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Class A Ordinary Share | MOption exerciseAcquired | +830 | $15.47 | +$12,840.1 | 13,376 | Direct | |
| Feb 2, 2026 | Class A Ordinary Share | SSaleDisposed | −830 | $45.00 | −$37,350 | 12,546 | Direct | |
| Feb 3, 2026 | Class A Ordinary Share | MOption exerciseAcquired | +12,528 | $15.47 | +$193,808.16 | 25,074 | Direct | |
| Feb 3, 2026 | Class A Ordinary Share | SSaleDisposed | −12,528 | $45.27 | −$567,142.56 | 12,546 | Direct | |
| Feb 4, 2026 | Class A Ordinary Share | MOption exerciseAcquired | +2,602 | $15.47 | +$40,252.94 | 15,148 | Direct | |
| Feb 4, 2026 | Class A Ordinary Share | SSaleDisposed | −2,602 | $45.02 | −$117,142.04 | 12,546 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Class A Ordinary Shares | MOption exerciseDisposed | −830 | $0.00 | $0 | 17,930 | Direct | |
| Feb 3, 2026 | Class A Ordinary Shares | MOption exerciseDisposed | −12,528 | $0.00 | $0 | 5,402 | Direct | |
| Feb 4, 2026 | Class A Ordinary Shares | MOption exerciseDisposed | −2,602 | $0.00 | $0 | 2,800 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.